Synergistic Cranial Nerve Stimulation Systems

Publication ID: 24-11857792_0003_PTD
Published: October 28, 2025
Category:Synergistic Combinations

Legal Citation

pr1or.art Inc., “Synergistic Cranial Nerve Stimulation Systems,” Published Technical Disclosure No. 24-11857792_0003_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857792_0003_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,792.

Summary of the Inventive Concept

Integrating innovative technologies like AI, IoT, blockchain, and novel biomaterials with implantable neuromodulation devices to create more effective and personalized treatments for various disorders, including sleep apnea, chronic pain, and movement disorders.

Background and Problem Solved

The original patent disclosed methods for stimulation of cranial nerves to treat various disorders. However, these methods had limitations in terms of signal efficacy, patient confidentiality, and real-time monitoring. The new inventive concept addresses these limitations by combining the original patented technology with distinct technologies to create a more powerful system.

Detailed Description of the Inventive Concept

The inventive concept comprises an implantable neuromodulation device integrated with a machine learning module to predict sleep disorder episodes and adjust the neuromodulation signal accordingly. Additionally, a blockchain-based secure communication protocol ensures data integrity and patient confidentiality. An IoT-based sensor network monitors patient physiological data and adjusts the neuromodulation signal in real-time. Novel biomaterial-based electrode designs enhance signal efficacy. AI-powered algorithms analyze patient-specific data to optimize the neuromodulation signal for individualized treatment outcomes.

Novelty and Inventive Step

The new claims introduce the integration of AI, IoT, blockchain, and novel biomaterials with implantable neuromodulation devices, which is not disclosed in the original patent. This synergistic combination provides a more effective and personalized treatment approach, which is not obvious from the original patent.

Alternative Embodiments and Variations

Alternative embodiments could include using different machine learning algorithms, varying the type of IoT sensors, or incorporating additional distinct technologies. Variations could include adapting the system for different disorders or using different biomaterials for the electrode design.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential in the medical device industry, particularly in the fields of sleep disorders, chronic pain, and movement disorders. The target market includes hospitals, clinics, and medical research institutions.

Field of Art

Biomedical engineering, specifically neural stimulation and implantable medical devices for treating neurological and sleep disorders

Person of Ordinary Skill (PHOSITA) Profile

A biomedical engineer or medical device researcher with expertise in neural stimulation technologies, implantable device design, signal processing, and understanding of neurological disorder treatments

Obviousness Rationale

A person of ordinary skill would recognize that integrating modern digital technologies like AI, IoT, and blockchain with existing neural stimulation devices represents a predictable evolution of medical device design. The core neuromodulation technique remains fundamentally consistent with the source patent, while the proposed technological enhancements represent standard approaches to improving medical device functionality and personalization.

Obvious Combinations & Variations

Source Patent Element
Implantable neuromodulation device targeting cranial nerves for sleep disorders
PTD Variation
Adding machine learning module to predict and adjust neuromodulation signals
Obviousness Reasoning
Adaptive signal processing is a known technique in medical device design, and applying machine learning to optimize neural stimulation represents a predictable technological improvement with a reasonable expectation of success
Source Patent Element
Neuromodulation device targeting hypoglossal nerve for sleep apnea
PTD Variation
Incorporating IoT sensor network for real-time physiological monitoring and signal adjustment
Obviousness Reasoning
Real-time monitoring and dynamic treatment adjustment are standard design approaches in implantable medical technologies, representing an obvious extension of existing device capabilities
Source Patent Element
Implantable device with specific cervical region placement
PTD Variation
Implementing blockchain-based secure communication protocol for data integrity
Obviousness Reasoning
Data security and privacy protocols are standard considerations in modern medical device design, representing a logical and predictable technological enhancement
Source Patent Element
Neuromodulation targeting multiple cranial nerve types
PTD Variation
Using novel biomaterial-based electrode designs to enhance signal efficacy
Obviousness Reasoning
Material science improvements in electrode design are routine in medical device engineering, representing an obvious approach to incrementally improving device performance
Source Patent Element
Cranial nerve stimulation for treating various disorders
PTD Variation
Implementing AI-powered algorithms for patient-specific treatment optimization
Obviousness Reasoning
Personalized medical treatment through computational analysis is a known and predictable approach in modern medical technology development
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857792 and the disclosed technological variations, a person having ordinary skill in the art would find the proposed neuromodulation system innovations obvious and lacking inventive merit. The integration of AI, IoT, blockchain, and advanced biomaterials represents predictable technological extensions of existing neural stimulation device design, thereby rendering potential patent claims obvious and unpatentable under 35 U.S.C. ยง 103.

Original Patent Information

Patent NumberUS 11,857,792
TitleMethods for stimulation of cranial nerves
Assignee(s)NuXcel2, L.L.C.